---
document_datetime: 2023-09-21 20:36:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/abecma-epar-all-authorised-presentations_en.pdf
document_name: abecma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6736114
conversion_datetime: 2025-12-28 10:33:42.621116
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength               | Pharmaceutical Form     | Route of Administration   | Immediate Packaging   | Content (concentration)            | Pack size      |
|------------------|-------------------|------------------------|-------------------------|---------------------------|-----------------------|------------------------------------|----------------|
| EU/1/21/1539/001 | Abecma            | 260 - 500 x 10 6 cells | Dispersion for infusion | Intravenous use           | Bag (EVA)             | patient specific, up to 100 ml max | 1 or more bags |